RSV Immunization (Beyfortus) Update

We are excited to offer Beyfortus (RSV immunization with preventative antibody) this year, starting the first week of October.

RSV immunization is recommended for pregnant women (Abrysvo) and for infants (Beyfortus) ~ please see this helpful CDC link for more general information.

Specific CDC guidance on Beyfortus, including criteria for immunization, can be found here.

The State of CT has assured us that we will have sufficient supply for all infants younger than 8 months and those infants 8 to 19 months who meet specific criteria for Beyfortus over the RSV season.

However, the state is shipping Beyfortus to us in small batches.

In accordance with the guidance from Yale Pediatric Infectious Disease expert Dr. Thomas Murray, we will be providing Beyfortus with our first priority being the youngest infants and those with specific high-risk medical conditions (outlined by the CDC), as these babies are at greatest risk for more severe disease and complications.

We will contact you when your infant can receive Beyfortus in our office, based on the prioritization list.

It is recommended that all pregnant women receive the RSV immunization (Abrysvo) when available, as guided by their doctor. Infants born to mothers who receive the RSV immunization may still need to be immunized with Beyfortus.

If you are expecting a new baby in the coming months, we recommend your infant receive Beyfortus in the hospital shortly after birth.

Thank you in advance for your patience and understanding!